Sotac Pharmaceuticals Interest Expense

Interest Expense of Sotac Pharmaceuticals is -16.57 M INR in 2026.

Interest Expense of Sotac Pharmaceuticals changed from -15.23 M INR to -16.57 M INR, representing a 8.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Sotac Pharmaceuticals historically and in real time.